Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 5Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2NSCLC 2Brain Neoplasms 2Adenocarcinoma of Lung 2Solid Tumor Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1Non Squamous Non-small Cell Lung Cancer 1Neoplasms 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Melanoma 1Lymphatic Metastasis 1Lung Non-Squamous Non-Small Cell Carcinoma 1Lung Diseases, Interstitial 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Advanced Solid Tumor 1

Interventions

toripalimab 2trastuzumab deruxtecan 1tislelizumab 1envafolimab 1enfortumab vedotin 1conteltinib 1Pemetrexed 1Oxaliplatin 1Injections 1Gemcitabine 1Cisplatin 1Carboplatin 1Capecitabine 1CD3 Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Solid Tumor × Pemetrexed × Clear all
NCT07157956 2025-09-05

CVL006-T1002

Convalife (Shanghai) Co., Ltd.

Phase 1/2 Not yet recruiting
318 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡